Day: April 12, 2021

NMPA Approves Toripalimab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma who Failed Platinum-Containing Chemotherapy or Progressed within 12 Months of Neoadjuvant or Adjuvant Platinum-Containing Chemotherapy

PRESS RELEASES

3rd indication approved for Toripalimab in China SHANGHAI, China, April 12, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China has granted a conditional approval to toripalimab for […]

Continue reading

Industry Leading SAFR Facial Recognition for Live Video Integrated with Geutebrück VMS

PRESS RELEASES

Featuring real-time, automated, low-bias identification of opt-in staff and persons of interest Gbruck-SAFR SEATTLE, April 12, 2021 (GLOBE NEWSWIRE) — SAFR from RealNetworks, Inc. (NASDAQ: RNWK) today announced that its SAFR facial recognition system for live video is now integrated with the Geutebrück G-Core VMS (Video Management System). SAFR for Geutebrück is an AI layer […]

Continue reading

Colliers releases first Global Impact Report

PRESS RELEASES

Development of full impact position and comprehensive strategy underway for 2021 TORONTO, April 12, 2021 (GLOBE NEWSWIRE) — Colliers (NASDAQ, TSX: CIGI), a leading diversified professional services and investment management company, published its first annual Global Impact Report, highlighting its commitment to embedding environmental, social and corporate governance (ESG) best practices across the organization. In […]

Continue reading